168 results
Page 3 of 9
8-K
EX-99.1
ncumqjei
9 Mar 21
DURECT Corporation Announces Publication of DUR-928’s Mechanism of Action
9:57am
8-K
EX-1.1
men89z913w5
5 Feb 21
DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock
4:48pm
8-K
EX-99.1
2tyfq0o xqwgrknhbo
16 Dec 20
DURECT Corporation Announces DUR-928 Granted FDA Fast Track Designation for Treatment of Alcoholic Hepatitis
9:15am
8-K
EX-10.1
ray0x7v 06g
2 Nov 20
DURECT Corporation Appoints Dr. Norman Sussman as Chief Medical Officer
4:16pm
8-K
EX-99.1
xgl hj5b8mu08
2 Nov 20
DURECT Corporation Announces Third Quarter 2020 Financial Results and Update of Programs
12:00am
8-K
EX-99.1
7hei498
23 Sep 20
Other Events
9:01am
8-K
EX-99.1
xr0wnd
3 Aug 20
DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs
4:21pm
8-K
EX-99.1
p9f7zxdef xqqe5es
1 Jul 20
Other Events
9:01am
8-K
EX-10.1
nymiph
18 Jun 20
Departure of Directors or Certain Officers
4:30pm